interferon beta-1a
interferon beta-1a structure
|
Common Name | interferon beta-1a | ||
|---|---|---|---|---|
| CAS Number | 145258-61-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | Interferonbeta1a/Humaninterferonbeta1a |
|---|---|
| Synonym | More Synonyms |
| Storage condition | -70°C |
|---|
| RTECS | NM9701100 |
|---|
|
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.
J. Neurol. Neurosurg. Psychiatr. 84(11) , 1186-91, (2013) To investigate the associations of serum lipid profile with disease progression in high-risk clinically isolated syndromes (CIS) after the first demyelinating event.High density lipoprotein cholestero... |
|
|
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Drug Des. Devel. Ther. 6 , 175-86, (2012) Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system, traditionally considered to be an autoimmune, demyelinating disease. Based on this understanding, the initial ... |
|
|
Emerging injectable therapies for multiple sclerosis.
Lancet Neurol. 12(11) , 1115-26, (2013) Available treatment options for relapsing-remitting multiple sclerosis (MS) have expanded in recent years, and several injectable therapies are under development. In this Rapid Review, we summarise em... |
| INTERFERON BETA-1A |